Research programme: CAR T cell therapies - Coeptis Therapeutics
Alternative Names: Research programme: CAR T cell therapies - Coeptis Therapeutics/University of Pittsburgh; SNAP-CAR NK cell therapy - Coeptis TherapeuticsLatest Information Update: 15 May 2024
Price :
$50 *
At a glance
- Originator Coeptis Therapeutics
- Developer Coeptis Therapeutics; University of Pittsburgh
- Class Antineoplastics; CAR-T cell therapies; Gene therapies; Immunotherapies
- Mechanism of Action Immunologic cytotoxicity; T lymphocyte replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Solid tumours
- Research Autoimmune disorders